보도 자료

Apr 17, 2024

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, officially kicked off its global 2024 Curiosity Cube tour today in Darmstadt, Germany.

Apr 16, 2024

Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind.

Feb 13, 2024

Teaser text.

Feb 01, 2024

Nov 25, 2022

Merck, the U.S. and Canada Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash. The business combination is expected to enable the Life Science business to provide its customers with comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain. The Life Science business plans to further invest over € 500 million to scale up Exelead’s technology over the next ten years.

Nov 01, 2022

Teaser text.

Jul 15, 2021

Press Release Merck 1606 Headline ROW

May 11, 2021

Press Release 0505 Teaser ROW

Feb 04, 2021

Test for Teaser PR ROW

Jan 08, 2021

Teaser Headline Merck

Dec 04, 2020

Aug 19, 2019